KURE · KraneShares MSCI All China Health Care Index ETF

$18.30
−0.8% · 1 day, price
Fact sheet
Share ▾
Share on XDownload as PDF
Embed ▾

Free to use with the credit link. It updates every trading night.

Fund card

<iframe src="https://etfiq.com/embed/fund/kure/" title="ETFIQ KURE analysis" width="100%" height="420" loading="lazy" style="border:0;max-width:600px"></iframe>
<p>Data: <a href="https://etfiq.com/funds/kure">ETFIQ KURE analysis</a></p>

How to embed ETFIQ charts

KURE tracks an index and returned −1.9% over the past year.

1-year total return
−1.9%to Nov 12, 2026
Expense ratio
0.65%a year
Net assets
$114mon Nov 11, 2026
Equity fund · Tracks an indexExpense ratio 0.65%Fund assets $114m on Nov 11, 2026First traded Feb 1, 2018Benchmark Its own holdings, as of Nov 11, 2026; no other fund tracks the MSCI China All Shares Healthcare 10/40 Index, the narrower index its shareholder report namesFund page at the issuer ↗SEC filings ↗Dividend history

KURE returned −1.9% over the year to Nov 12, 2026, charges 0.65% a year and holds $114m in net assets on Nov 11, 2026.

Promise check: Not measured

Growth of $10,000

KURE, 1 year

Total return, distributions reinvested, Nov 12, 2025 to Nov 12, 2026. No second line: its benchmark is its own holdings, which have no daily price series.

KURE $9,814 −1.9%Returns from daily closes. Data
Scorecard · vs

KURE risk and return scorecard

Not measured: no scorecard was computed for this fund.

Method

Total return

What you earned

KURE +1.2%: total return over one month to Nov 12, 2026.
$10,000 in KURE would be $10,120, over one month to Nov 12, 2026.
KURE+1.2%
KURE −1.9%: total return over three months to Nov 12, 2026.
$10,000 in KURE would be $9,810, over three months to Nov 12, 2026.
KURE−1.9%
KURE +8.7%: total return over six months to Nov 12, 2026.
$10,000 in KURE would be $10,870, over six months to Nov 12, 2026.
KURE+8.7%
KURE +7.4%: total return year to date, Dec 31, 2025 to Nov 12, 2026.
$10,000 in KURE would be $10,740, year to date, Dec 31, 2025 to Nov 12, 2026.
KURE+7.4%
KURE −1.9%: total return over one year to Nov 12, 2026.
$10,000 in KURE would be $9,810, over one year to Nov 12, 2026.
KURE−1.9%
KURE +4.8%: total return over three years to Nov 12, 2026.
$10,000 in KURE would be $10,480, over three years to Nov 12, 2026.
KURE+4.8%
KURE −35.8%: total return over five years to Nov 12, 2026.
$10,000 in KURE would be $6,420, over five years to Nov 12, 2026.
KURE−35.8%
KURE −9.6%: total return since launch to Nov 12, 2026.
$10,000 in KURE would be $9,040, since launch to Nov 12, 2026.
KURE−9.6%
Fees over time · hypothetical
Fees paid
$631
Of the amount
6.3%

At KURE’s 0.65% a year, taken each year from the amount after growth. Hypothetical.

Cost to trade · hypothetical
One way
$58.50
Round trip
$117.00
A year
$117.00

One way: half its 30-day median bid-ask spread, as of Nov 11, 2026. A round trip buys and later sells the same size. Hypothetical. Trading page

not read by ETFIQ

How concentrated, and what does it cost?

−1.9%
Total return, 1 year
0.65%
Expense ratio
50
Holdings
−53.1%
Below its high
3.7%
12-month yield, capital gains included, on its starting price
$0.7147
Last payment (paid annually), ex-date Dec 22, 2025
Sector mix
Cost against like funds

12 committee seats read KURE on data as of Nov 12, 2026: 1 Supports, 0 Mixed, 4 Challenges, 7 without enough data.

1 Supports0 Mixed4 Challenges7 Not enough data
  • Bogle
  • Graham
  • Buffett & Munger
  • Lynch
  • Templeton
  • Dalio
  • Marks
  • Druckenmiller
  • Swensen
  • Wood
  • Livermore
  • Skeptic

Watch the committee read KURE How the committee works

12 seats on KURE, as of Nov 12, 2026: 1 Supports, 4 Challenges, 7 Not enough data.

In the tradition ofJohn BogleBogle-style Low CostChallenges
In the tradition ofBenjamin GrahamGraham-style Margin of SafetyNot enough data
In the tradition ofWarren Buffett & Charlie MungerBuffett & Munger-style QualityNot enough data
In the tradition ofPeter LynchLynch-style Growth at a Reasonable PriceNot enough data
In the tradition ofJohn TempletonTempleton-style Global ContrarianNot enough data
In the tradition ofRay DalioDalio-style All-WeatherChallenges
In the tradition ofHoward MarksMarks-style Cycles & RiskNot enough data
In the tradition ofStanley DruckenmillerDruckenmiller-style Macro & LiquidityChallenges
In the tradition ofDavid SwensenSwensen-style DiversificationChallenges
In the tradition ofCathie WoodWood-style Disruptive InnovationNot enough data
In the tradition ofJesse LivermoreLivermore-style Trend FollowingSupports
Uses ETFIQ’s measuresETFIQ SkepticETFIQ’s own seatNot enough data
Put KURE to the committee →See all seats →No investor named is affiliated with or endorses ETFIQ. Not investment advice.

Risk Officer

Risk check

What to look at before you hold KURE. Not advice.

As of Nov 13, 2026, KURE crossed 1 of 5 ETFIQ risk lines.

OverlapNot publishedNot published
Trading cost30-day median spread 1.17%30-day median bid-ask spread 1.17% (KraneShares (fund page), Nov 11, 2026), above 0.5%.Flag
Premium or discount95% of days within ±0.3241% of NAV, 0 days over 1%, Nov 11, 2026 to Nov 11, 2026Clear
ConcentrationTop 10 holdings are 54.4% of the fundClear
ClosureNo closure flagClear

Lines and sources: Method. Check several funds at once on My Portfolio.

More on KURE

Every number below is on this page. Open what you need.

The week's ETF fund flows, by email on Sundays.

One-click unsubscribe. See Privacy.

Price and total return, 1 year

$18.30−0.8%1 day, priceClose, Nov 12, 2026

Total return adds every distribution, reinvested. Computed by ETFIQ from Tiingo daily prices.

Source: Tiingo end-of-day prices. Data as of Nov 12, 2026. Updated every trading night. Report a data error

KURE returns by window: total return, cash paid and price change
WindowTotal returnS&P 500 (SPY)
1M Oct 13 – Nov 12, 2026+1.2%−2.7%
3M Aug 13 – Nov 12, 2026−1.9%−2.4%
6M May 14 – Nov 12, 2026+8.7%+1.7%
YTD Dec 31, 2025 – Nov 12, 2026+7.4%+11.9%
1Y Nov 12, 2025 – Nov 12, 2026−1.9%+12.0%
3Y Nov 13, 2023 – Nov 12, 2026+4.8%+78.3%
5Y Nov 12, 2021 – Nov 12, 2026−35.8%+73.3%
Since launch Feb 1, 2018 – Nov 12, 2026−9.6%+207.3%
Since launch, annualised Feb 1, 2018 – Nov 12, 2026−1.1%–

Total returns, distributions reinvested.

Source: Tiingo end-of-day prices, with distributions reinvested.

KURE key stats

52-week high, daily closes to Nov 12, 2026 (ETFIQ)$19.72 on Nov 14, 2025
52-week low, daily closes to Nov 12, 2026 (ETFIQ)$14.52 on Jun 9, 2026
Close on Nov 12, 2026, within that range (ETFIQ)$18.30, 73% of the way from the low to the high
Holdings50
Top ten weight54.4%
Range, beta and R-squared computed by ETFIQ from Tiingo daily prices.

Trading

as of Nov 11, 2026
Trading · KUREas of Nov 11, 2026
·
Not scored2 of 6 measured · Nov 11, 2026
0 · Hard to tradeIQ Liquidity Score100 · Trades like a giant
Cost for your order · one way, half its 30-day median spread
$1,000$5.850.58%
$10,000$590.58%
Premium or discount to NAV, Nov 11 close−0.32%
−0.5%95% of days within ±0.32% · the 1% band is off this scale+0.5%
How to tradeLimit: midpoint + 11¢ to buy, midpoint − 11¢ to sell.At the Nov 11 close of $18.45, that’s $18.56 to buy and $18.34 to sell.Its holdings close before New York; its price can drift from value late in the day.
Full trading page: components, premium history, dealers →

KURE for holders outside the US

US tax withheld on dividends, no treaty30%
Treaty rates on dividends (IRS table, read Oct 30, 2026)65 countries, 10% to 30%
KURE interest-related and short-term gain dividendsnot read by ETFIQ
US estate tax filing threshold, non-resident holders$60,000
Share classDistributing

KURE is a US fund. Stock of US corporations counts as US property for a non-resident's estate. Facts from the IRS, not tax advice. How withholding and treaties work
Download all holdings

KURE top ten by weight, 54.4% of the fund, of its 50 equity positions, from the holdings published by its issuer for Nov 11, 2026. An index fund holds what the index holds, so this is the index. Source: the issuer’s own daily file.

BEONE MEDICINES LTD 6160 HKG 9.64%
INNOVENT BIOLOGICS INC 1801 HKG 8.14%
WUXI APPTEC CO LTD-A 603259 SHA 5.54%
AKESO INC 9926 HKG 4.15%
SINO BIOPHARMACEUTICAL 1177 HKG 3.91%
WUXI APPTEC CO LTD-H not published 3.19%

Source: the issuer’s own daily file. Data as of Nov 11, 2026. Updated each trading day. Last checked Nov 12, 2026.

About KURE

What it tracksnot read by ETFIQ
Fund typeEquity fund
Category (ETFIQ)Stocks · China region
Region (ETFIQ)Emerging markets
Expense ratio (497 XBRL, Jul 31, 2026)0.65%
Price$18.30
First tradedFeb 1, 2018
Net assets (issuer page, as of Nov 11, 2026)$114mReport
Benchmark (ETFIQ, from its filings)Its own holdings, as of Nov 11, 2026; no other fund tracks the MSCI China All Shares Healthcare 10/40 Index, the narrower index its shareholder report names
Stated benchmarkMSCI China All Shares Healthcare 10/40 Index (from its shareholder report). No ETF ETFIQ covers tracks it, so ETFIQ cannot price it.
Below its high (ETFIQ)−53.1%
Holdings50
Top ten weight54.4%
Cash, not in the top ten0.1%
Holdings published for (the issuer’s daily file)Nov 11, 2026
Holdings as of the close of (the issuer’s daily file)Nov 11, 2026
Already in the S&P 500, by weight (ETFIQ)0.0%
Active share vs the S&P 500 (ETFIQ)100.0%
Already in the Nasdaq-100, by weight (ETFIQ)0.0%
Promise checkNot measured. It names no index it tracks.

Questions people ask about KURE

How has KURE performed?
Over the year to Nov 12, 2026, KURE returned −1.9% with distributions reinvested. Over three years the number is +4.8%.
What does KURE cost?
The prospectus expense ratio is 0.65% a year.
What does KURE hold?
50 positions as published by its issuer for Nov 11, 2026, with the top ten at 54.4% of the fund. 0% of its weight is in stocks the S&P 500 also holds.
How far is KURE below its high?
53.1% below its high of Feb 17, 2021, measured on the reinvested series to Nov 12, 2026.
Sources and dates
Prices, KURE and S&P 500 (SPY)Tiingo end-of-day · Nov 12, 2026
Net assets, $114mIssuer page · Nov 11, 2026

Links are sources, not endorsements.

Cite this pageCitation, APA and Markdown

ETFIQ, KURE, stock fund, data as of Nov 12, 2026. https://etfiq.com/funds/kure

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data.

Embed this chart

Free to use with the credit link. Paste this where the chart should go; it updates every trading night.

KURE: KURE over 1 year: total return −1.9%. Data to Nov 12, 2026.
<figure style="margin:0;max-width:640px">
<iframe src="https://etfiq.com/embed/core/kure/" title="KURE: KURE over 1 year: total return −1.9%. Data to Nov 12, 2026." width="640" height="370" loading="lazy" style="border:0;max-width:100%;width:100%"></iframe>
<figcaption style="font:13px/1.5 sans-serif">KURE: KURE over 1 year: total return −1.9%. Data to Nov 12, 2026. Data: <a href="https://etfiq.com/funds/kure">ETFIQ</a></figcaption>
</figure>

How to embed ETFIQ charts

Get the ETFIQ Daily

The day's ETF flows, a comparison and one number. Every trading morning. About the Daily

The ETFIQ Daily and our other emails. Unsubscribe from any one in a click. See Privacy.

Snapshot, Nov 12, 2026. More on the tabs above.